Kentucky’s Approach to Drug Treatment and Medicaid Spending

Governor Beshear’s 2020 Initiative

By the end of 2020, Governor Andy Beshear of Kentucky prioritized saving lives. The state faced dual challenges: the COVID-19 pandemic and a high rate of drug overdoses. Acknowledging addiction as a disease that worsens in isolation, Beshear feared people would avoid treatment due to COVID-19.

Beshear aimed to ease access to drug treatment. Kentucky, along with over 40 other states, relaxed certain Medicaid restrictions. Most Kentuckians in substance abuse programs were Medicaid participants. Recovery centers could provide costly treatments without prior approval from state insurers.

Post-Pandemic Policy Continuation

As the pandemic subsided, several states reversed their Medicaid relaxations by 2023, requiring treatment centers to gain approval before offering addiction services. Kentucky did not follow this trend.

That year, Kentucky provided more than 1,100 long-term treatment spots, setting a state record with the most slots per capita nationwide. However, these expenses began to pile up, raising concerns.

In February 2025, the state’s spending on health and addiction treatment reached an unparalleled $2.3 billion.

Reports highlighted rampant billing, primarily from the drug treatment sector, with some providers exploiting the system for profit.

Challenges and Allegations

Addiction Recovery Care (ARC), Kentucky’s largest provider, became a focal point, receiving substantial state funds. In 2023, ARC faced accusations of falsifying billing after a whistleblower lawsuit by former employees. Although a settlement was reached, ARC denied knowingly defrauding Medicaid.

The Department of Justice charged Tim Robinson, ARC’s leader, with wire fraud and money laundering. The company, amid decreased funding, closed most facilities, reducing treatment beds by 56%.

Political Responses and Expert Opinions

Republicans, by 2025, sought to mandate insurer pre-approvals for treatment services. Governor Beshear vetoed the bill, citing potential healthcare delays. Despite opposition, the Republicans overrode the veto.

Numerous warnings from Medicaid insurers and experts characterized Kentucky’s policies as lenient and ripe for abuse. Medicaid expenses surged for services like peer support, often not aligned with reduced overdose fatalities.

Kentucky’s actions, according to Medicaid insurers, permitted billing for services not effectively improving health outcomes. In state discussions, experts called for reinstatement of prior authorization to curb abuse.

Conclusion and Future Perspectives

Although overdose deaths dropped in Kentucky, experts credit national trends like reduced opioid prescriptions and naloxone usage. Amidst consecutive overdose death declines, Beshear defended his policies, emphasizing lives saved.

Beshear maintained that expanding Medicaid access was crucial to combatting addiction effectively. Future legislative adjustments reflect ongoing debates about balancing accessibility with accountability in public health policy.